Wednesday's analyst calls: Eli Lilly gets a price target increase, Goldman sees Tesla decline

Investment Strategy News

Wednesday's analyst calls: Eli Lilly gets a price target increase, Goldman sees Tesla decline
Stock MarketsTesla IncEli Lilly And Co
  • 📰 CNBC
  • ⏱ Reading Time:
  • 20 sec. here
  • 7 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 72%

Tesla and a pharmaceutical giant were among the stocks analysts were talking about on Wednesday.

Goldman Sachs raised its price target on Tesla, but it still sees a a decline for the electric vehicle maker. Barclays also hiked its Eli Lilly target, indicating roughly 10% upside. Check out the latest calls and chatter below. All times ET. 6:04 a.m.: Target has 'exceptionally strong merchandising' but missing upside drivers, Piper Sandler says Piper Sandler thinks Target is a safe play for investors with a longer investment horizon.

mountain 2024-07-01 since July 2 "While we continue to believe that Tesla is well positioned for longer-term growth given its strong position in the EV and clean energy markets ... we expect weaker market conditions to weigh on earnings in the near to intermediate term. We also see valuation as full," analyst Mark Delaney wrote. He has a neutral rating on Tesla. — Fred Imbert

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

CNBC /  🏆 12. in US

Stock Markets Tesla Inc Eli Lilly And Co Target Corp Business News

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Watchdog Calls on Eli Lilly to Denounce Supreme Court Puppetmaster’s FirmWatchdog Calls on Eli Lilly to Denounce Supreme Court Puppetmaster’s FirmThe Supreme Court puppetmaster’s firm has worked with Eli Lilly, according to leaked records.
Read more »

Novo Nordisk stock price falls after Eli Lilly weight loss drug outperforms OzempicNovo Nordisk stock price falls after Eli Lilly weight loss drug outperforms OzempicPolitical News and Conservative Analysis About Congress, the President, and the Federal Government
Read more »

Microsoft and Eli Lilly are among the most overbought stocks as the first half endsMicrosoft and Eli Lilly are among the most overbought stocks as the first half endsThese are Wall Street's most overbought stocks.
Read more »

Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug dataHealthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug dataDrugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant for doctors.
Read more »

Healthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug dataHealthy Returns: Eli Lilly, other drugmakers show off encouraging weight loss drug dataDrugmakers showed off data on weight loss and diabetes drugs. Also, Oracle announced the general availability of AI documentation assistant for doctors.
Read more »

DuPont draws suitors for its water unit, plus what's driving Eli Lilly's bounceDuPont draws suitors for its water unit, plus what's driving Eli Lilly's bounceThe Investing Club holds its 'Morning Meeting' every weekday at 10:20 a.m. ET.
Read more »



Render Time: 2025-02-22 23:01:45